Literature DB >> 36268240

Liver cirrhosis and sarcopenia: a dreadful combination.

Mohammad Shafi Kuchay1, José Ignacio Martínez-Montoro2, José Carlos Fernández-García3, Bruno Ramos-Molina4, Camilo Julio Llamoza-Torres5.   

Abstract

Entities:  

Year:  2022        PMID： 36268240      PMCID： PMC9577976          DOI： 10.21037/hbsn-22-355

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   8.265


× No keyword cloud information.
  14 in total

1.  Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients.

Authors:  G D'Amico; L Pasta; A Morabito; M D'Amico; M Caltagirone; G Malizia; F Tinè; G Giannuoli; M Traina; G Vizzini; F Politi; A Luca; R Virdone; A Licata; L Pagliaro
Journal:  Aliment Pharmacol Ther       Date:  2014-03-24       Impact factor: 8.171

2.  Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis.

Authors:  Xinxing Tantai; Yi Liu; Yee Hui Yeo; Michael Praktiknjo; Ezequiel Mauro; Yuhei Hamaguchi; Cornelius Engelmann; Peng Zhang; Jae Yoon Jeong; Jeroen Laurens Ad van Vugt; Huijuan Xiao; Huan Deng; Xu Gao; Qing Ye; Jiayuan Zhang; Longbao Yang; Yaqin Cai; Yixin Liu; Na Liu; Zongfang Li; Tao Han; Toshimi Kaido; Joo Hyun Sohn; Christian Strassburg; Thomas Berg; Jonel Trebicka; Yao-Chun Hsu; Jan Nicolaas Maria IJzermans; Jinhai Wang; Grace L Su; Fanpu Ji; Mindie H Nguyen
Journal:  J Hepatol       Date:  2021-11-14       Impact factor: 30.083

Review 3.  EASL Clinical Practice Guidelines on nutrition in chronic liver disease.

Authors: 
Journal:  J Hepatol       Date:  2018-08-23       Impact factor: 25.083

4.  Exercise and physical activity for patients with end-stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list.

Authors:  Andrés Duarte-Rojo; Astrid Ruiz-Margáin; Aldo J Montaño-Loza; Ricardo U Macías-Rodríguez; Arny Ferrando; W Ray Kim
Journal:  Liver Transpl       Date:  2018-01       Impact factor: 5.799

Review 5.  Sarcopenia from mechanism to diagnosis and treatment in liver disease.

Authors:  Srinivasan Dasarathy; Manuela Merli
Journal:  J Hepatol       Date:  2016-08-08       Impact factor: 25.083

6.  Testosterone therapy increases muscle mass in men with cirrhosis and low testosterone: A randomised controlled trial.

Authors:  Marie Sinclair; Mathis Grossmann; Rudolf Hoermann; Peter W Angus; Paul J Gow
Journal:  J Hepatol       Date:  2016-06-14       Impact factor: 25.083

7.  Causes of death in people with liver cirrhosis in England compared with the general population: a population-based cohort study.

Authors:  Sonia Ratib; Kate M Fleming; Colin J Crooks; Alex J Walker; Joe West
Journal:  Am J Gastroenterol       Date:  2015-07-14       Impact factor: 10.864

8.  European Working Group on Sarcopenia in Older People (EWGSOP2) Criteria With Population-Based Skeletal Muscle Index Best Predicts Mortality in Asians With Cirrhosis.

Authors:  Abhinav Anand; Srikant Mohta; Samagra Agarwal; Sanchit Sharma; Srikanth Gopi; Deepak Gunjan; Kumble S Madhusudhan; Namrata Singh; Anoop Saraya
Journal:  J Clin Exp Hepatol       Date:  2021-04-08

9.  Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis.

Authors:  Aldo J Montano-Loza; Andres Duarte-Rojo; Judith Meza-Junco; Vickie E Baracos; Michael B Sawyer; Jack X Q Pang; Crystal Beaumont; Nina Esfandiari; Robert P Myers
Journal:  Clin Transl Gastroenterol       Date:  2015-07-16       Impact factor: 4.488

10.  Association of loss of muscle mass with mortality in liver cirrhosis without or before liver transplantation: A systematic review and meta-analysis.

Authors:  Ke-Vin Chang; Jin-De Chen; Wei-Ting Wu; Kuo-Chin Huang; Der-Sheng Han
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.